VUB | Infopunt Proefdieronderzoek
Huub Schellekens email address & phone number | Feenstra HR Business Partner contact information - RocketReach
Immunogenicity and aggregation of therapeutic proteins - American ...
For complex biosimilars in EU: drop clinical comparability
Elles de Bruin | Writers Unlimited
Huub Schellekens | European Association of Hospital Pharmacists
Variability of Biologics and its Impact on Biosimilar Development - European Medical Journal
Huub Schellekens – Studium Generale Universiteit Utrecht
Personalised medicine produced in a “Bionexpresso” - News - Utrecht University
Cv huub schellekens complet by Ricardo Guerrero - Issuu
SciELO - Saúde Pública - Hubs to spread technology and save lives Hubs to spread technology and save lives
Huub Schellekens, Professor of pharmaceutical biotechnology at Utrecht University: "We need 20 billion doses for the entire world population"
Huub Schellekens (@HuubSchellekens) / Twitter
D16 Training - Conference Besides having a public session focusing on a specific theme on each of the workshops (M7, M12, M20, M
Variability of Biologics and its Impact on Biosimilar Development
Daan CROMMELIN | Professor Emeritus | Utrecht University, Utrecht | UU | Department of Pharmaceutical Sciences | Research profile
Huub Schellekens - HR Business Partner - Feenstra | LinkedIn
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
eLearning module: Improving confidence by explaining key terminology – Biosimilars: From concern to confidence
Catalogus Professorum - Prof Detail
ERIKA LIETZAN
A new way to manufacture small batches of biopharmaceuticals on demand | MIT News | Massachusetts Institute of Technology
Professor Schellekens maakt medicijnen zelf - Zembla - BNNVARA
Biosimilars bieden oplossing voor stijgende kost onco- en hematologische behandelingen - Actualiteit - Belgian Oncology & Hematology News - Artsenkrant.com
De Affaire Buck - Andere Tijden
